Premium
Modulation of cytokine production by monocytes and developing‐dendritic cells under the influence of leukemia and lymphoma cell products
Author(s) -
Motta Juliana Maria,
Rumjanek Vivian Mary
Publication year - 2021
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1002/cbin.11514
Subject(s) - cytokine , tumor necrosis factor alpha , cancer research , monocyte , immunology , leukemia , myeloid leukemia , biology , k562 cells , tumor microenvironment , lymphoma , immune system
Abstract Cytokines and other soluble factors released by tumor cells play an important role in modulating immune cells to favor tumor development. Monocyte differentiation into macrophages or dendritic cells (DCs) with specific phenotypes is deeply affected by tumor signals and understanding this context is paramount to prevent and propose new therapeutic possibilities. Hence, we developed a study to better describe the modulatory effects of leukemia and lymphoma cell products on human monocytes and monocyte‐derived DCs secretion of cytokines such as interleukin (IL)‐1β, tumor necrosis factor‐α (TNF‐α), IL‐6, and IL‐12. Except with the promyelocytic leukemia cell supernatants (HL‐60), the other two tumor supernatants (chronic myeloid leukemia, K562 and Burkitt lymphoma, DAUDI) increased both TNF‐α and IL‐1β production by monocytes and monocytes undergoing differentiation. This effect was neither explained by alterations of cell number in culture nor by the high amount of vascular endothelial growth factor (VEGF) present in the tumor supernatants. Moreover, all supernatants used were able to induce drastic reduction of IL‐12 secretion by cells induced to activation, suggesting a negative interference with Th1 antitumoral responses that should be a huge advantage for tumor progression.